Locoregional irradiation for inflammatory breast cancer: Effectiveness of dose escalation in decreasing recurrence

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 5, 2000, Pages 1191-1200

  Liao, Zhongxing ^a   Strom, Eric A ^a   Buzdar, Aman U ^a   Singletary, S Eva ^a   Hunt, Kelly ^a   Allen, Pamela K ^a   McNeese, Marsha D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Accelerated radiation; Dose escalation; Hyperfractionation; Inflammatory breast cancer; Locally advanced breast cancer; Multimodal management; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PREDNISONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARM EDEMA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; INFLAMMATORY DISEASE; LYMPH NODE IRRADIATION; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MASTECTOMY; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PNEUMONIA; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; RIB FRACTURE; SURVIVAL; SURVIVAL RATE; THORAX WALL; THORAX WALL DEFECT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOSE FRACTIONATION; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDNISONE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VINCRISTINE;

EID: 0034662077     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00561-7     Document Type: Article

References (22)

1. Taylor G.W., Meltzer A. Inflammatory carcinoma of the breast. Am J Cancer. 33:1938;33-49.
2. Haagensen C. Disease of the breast. 2nd ed. Philadelphia, PA: W. B. Saunders; 1971. p. 576-584.
3. Levine P.H., Steinhorn S.C., Ries L.G., et al. Inflammatory breast cancer The experience of the surveillance, epidemiology, and end results (SEER) Program . J Natl Cancer Inst. 74:1985;291-297.
4. Barker J.L., Nelson A.J., Montague E.D. Inflammatory carcinoma of the breast. Radiology. 121:1976;173-176.
5. Buzdar A.U., Singletary S.E., Booser D.J., et al. Combined modality treatment of stage III and inflammatory breast cancer. M. D. Anderson Cancer Center experience. Surg Oncol Clin North Am. 4:1995;715-734.
6. Zylberberg B., Salat-Baroux J., Ravina J.H., et al. Initial chemoimmunotherapy in inflammatory carcinoma of the breast. Cancer. 49:1982;1537-1543.
7. Rouesse J., Friedman S., Sarrazin D., et al. Primary chemotherapy in the treatment of inflammatory breast carcinoma A study of 230 cases from the Institut Gustave-Roussy . J Clin Oncol. 4:1986;1765-1771.
8. Chevallier B., Bastit P., Craic Y., et al. The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer. 67:1993;594-601.
9. Maloisel F., Dufour P., Bergerat J.P., et al. Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer. 65:1990;851-855.
10. Perez C.A., Fields J.N., Fracasso P.M., et al. Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer. 74:1994;466-476.
11. Israel L., Breau J.L., Morere J.F. Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. As phase II study of 25 cases with a median follow-up of 35 months. Cancer. 57:1986;24-28.
12. Elias E.G., Vachon D.A., Didolkar M.S., et al. Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast. Am J Surg. 162:1991;231-235.
13. Barker J.L., Montague E.D., Peters L.J. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy. Cancer. 45:1980;625-629.
14. Thoms W.J., McNeese M.D., Fletcher G.H., et al. Multimodality treatment for inflammatory breast cancer [letter; comment]. Int J Radiat Oncol Biol Phys. 19:1990;1107.
15. Beahrs OH, Henson DE, Hutter RV; et al., editors. American Joint Committee on Cancer: Manual for staging of cancer. Philadelphia, J.B. Lippincott; 1988.
16. Ueno N.T., Buzdar A.U., Singletary S.E., et al. Combined-modality treatment of inflammatory breast carcinoma Twenty years of experience at M. D. Anderson Cancer Center . Cancer Chemother Pharmacol. 40:1997;321-329.
17. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Statst Assoc. 53:1958;457-481.
18. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who received adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med. 337:1997;949-955.
19. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
20. Thomas F., Arriagada R., Spielmann M., et al. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy. Cancer. 76:1995;2286-2290.
21. Brun B., Otmezguine Y., Feuilhade F., et al. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer. 61:1988;1096-1103.
22. Pisansky T.M., Schaid D.J., Loprinzi C.L., et al. Inflammatory breast cancer Integration of irradiation, surgery, and chemotherapy . Am J Clin Oncol. 15:1992;376-387.